更新了MASLD病原发生的机制
Yuxuan Li1,2, Peipei Yang2, Jialu Ye2
1Department of Cardiology, State Key Laboratory of Transvascular Implantation Devices, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lipids in health and disease
|April 22, 2024
概括
由于生活方式的改变,代谢功能障碍相关的脂肪性肝病 (MASLD) 正在增加. 本综述探讨了MASLD发展和治疗挑战中的脂毒性,铁和肠道微生物.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
- 微生物组研究 微生物组研究
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 的患病率正在全球范围内增加,与过度营养和不活动等生活方式因素有关.
- MASLD与肥胖和代谢综合征有关,因此需要更深入地了解其病原性.
- 肝脏脂质的积累可以导致脂毒性,内质网膜压力,氧化压力,器官功能障碍和铁,导致MASLD及其进展到MASH.
研究的目的:
- 总结和评估脂毒性,铁和肠道微生物在MASLD病变发生中的作用.
- 阐明这些因素在MASLD发展中的潜在机制.
- 概述MASLD治疗当前的进展和挑战.
主要方法:
- 文献综述和对MASLD现有研究的综合.
- 评估将脂毒性,铁和肠道失调与肝脏疾病联系在一起的机制.
- 分析当前的治疗策略及其局限性.
主要成果:
- 肝脏脂毒性,铁和肠道微生物失生症是MASLD发展的关键因素.
- 这些因素调解细胞压力和器官功能障碍,促进肝脏脂肪和炎症.
- 这些元素的复杂相互作用为开发有效的药理疗法带来了重大挑战.
结论:
- 向脂毒性,铁和肠道微生物群是MASLD干预的有希望的途径.
- 需要进一步的研究来克服临床试验中的挑战,并确定有效的治疗方法.
- 了解这些致病机制对于开发用于MASLD的新型治疗策略至关重要.
相关概念视频
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:38Intralumenal Vesicles and Multivesicular Bodies
3.5K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.5K